ABL1 and deep vein thrombosis: Our patient had severe eosinophilia, thrombocytopenia, and thrombosis so we evaluated him for underlying primary HES by sending the FIP1L1–PDGFRA fusion gene, PDGFRB JAK2V617F mutation, CALR, and BCR‐ABL mutation.